{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:54:24Z","timestamp":1753869264648,"version":"3.41.2"},"reference-count":7,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Hematological Oncology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1002\/hon.3221","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T05:15:54Z","timestamp":1694150154000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiation therapy for patients with relapsed or refractory mantle cell lymphoma undergoing CD19\u2010targeted chimeric antigen receptor T\u2010cell therapy"],"prefix":"10.1002","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-9852","authenticated-orcid":false,"given":"Hazim S.","family":"Ababneh","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology Massachusetts General Hospital Harvard Medical School  Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Frigault","sequence":"additional","affiliation":[{"name":"Division of Hematology & Oncology Massachusetts General Hospital Harvard Medical School  Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirayu G.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Massachusetts General Hospital Harvard Medical School  Boston Massachusetts USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"key":"e_1_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.5904"},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1914347"},{"key":"e_1_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02370"},{"key":"e_1_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/BLOODADVANCES.2021006922"},{"key":"e_1_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.01797"},{"key":"e_1_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/BLOODADVANCES.2019030858"},{"key":"e_1_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2022.08.007"}],"container-title":["Hematological Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hon.3221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T15:09:53Z","timestamp":1711465793000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.3221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1002\/hon.3221"],"URL":"https:\/\/doi.org\/10.1002\/hon.3221","archive":["Portico"],"relation":{},"ISSN":["0278-0232","1099-1069"],"issn-type":[{"type":"print","value":"0278-0232"},{"type":"electronic","value":"1099-1069"}],"subject":[],"published":{"date-parts":[[2023,9,7]]},"assertion":[{"value":"2023-09-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e3221"}}